BD0610653
2,4-Dichloro-3-nitroquinoline , 95% , 132521-66-5
CAS NO.:132521-66-5
Empirical Formula: C9H4Cl2N2O2
Molecular Weight: 243.05
MDL number: MFCD05666285
| Pack Size | Price | Stock | Quantity |
| 100mg | RMB216.00 | In Stock |
|
| 250mg | RMB323.20 | In Stock |
|
| 1g | RMB806.40 | In Stock |
|
| 5g | RMB2822.40 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 102 °C(Solv: methanol (67-56-1); ethyl acetate (141-78-6)) |
| Boiling point: | 359.7±37.0 °C(Predicted) |
| Density | 1.593±0.06 g/cm3(Predicted) |
| storage temp. | -20°C Freezer |
| solubility | Chloroform (Slightly), Methanol (Slightly) |
| form | Solid |
| pka | -4.98±0.50(Predicted) |
| color | White to Off-White |
| InChI | InChI=1S/C9H4Cl2N2O2/c10-7-5-3-1-2-4-6(5)12-9(11)8(7)13(14)15/h1-4H |
| InChIKey | RSFJVCHKGRUCIC-UHFFFAOYSA-N |
| SMILES | N1C2C(=CC=CC=2)C(Cl)=C([N+]([O-])=O)C=1Cl |
Description and Uses
2,4-Dichloro-3-nitroquinoline is a chemotherapeutic drug that belongs to the class of epidermal growth factor receptor (EGFR) inhibitors. This agent has anticancer activity against cells in the G1 phase of the cell cycle and may also have some antiproliferative effects on tumor cells. 2,4-Dichloro-3-nitroquinoline binds to EGFR and inhibits the binding of epidermal growth factor (EGF) to its receptor. This binding causes the activation of downstream signaling pathways that regulate cell proliferation.
2,4-Dichloro-3-nitroquinoline has antitumor activity.
Safety
| Symbol(GHS) | ![]() GHS07 |
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H335 |
| Precautionary statements | P261-P305+P351+P338 |
| HS Code | 2933499090 |




![2,4-Dibromobenzo[d]thiazole](https://img.chemicalbook.com/CAS/GIF/887589-19-7.gif)


